98%
921
2 minutes
20
The endocannabinoid system plays a pivotal role in metabolic regulation, primarily through cannabinoid receptor-1 (CB1) signaling. In this study, we show that rimonabant (Rim), a selective non-restricted CB1 antagonist, induces substantial weight loss across multiple diet groups, although reduced food intake occurred only in the high-fat (HF) diet group. Rim enhanced brown adipose tissue (BAT) thermogenesis across all diets and visceral white adipose tissue (vWAT) thermogenesis in HF and high-carbohydrate (HC) diets. We identified CB1 expression in the gut's splanchnic and vagal neurons and found that CB1 modulation significantly influenced afferent splanchnic but not vagal neuronal activity. Furthermore, selective splanchnic, not vagal, afferent denervation eliminated Rim's anorectic effect. Mice lacking CB1 in sensory neurons (Nav1.8Cre/CB1) showed reduced diet-induced weight gain and diminished metabolic response to JD5037, a peripherally restricted CB1 antagonist. These findings emphasize the importance of CB1 signaling in sensory neurons as a key mechanism regulating energy homeostasis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329259 | PMC |
http://dx.doi.org/10.1016/j.isci.2025.113124 | DOI Listing |
Pharmacol Res Perspect
October 2025
Department of Nutritional Sciences, University of Georgia, Athens, Georgia, USA.
Exogenous cannabinoids have long been known to promote eating. However, the underlying mechanisms have not been completely elucidated, which is critical to understanding their utility. The orexin/hypocretin (OH) system of the lateral hypothalamus (LHA) has known anatomical, biochemical, and physiological interactions with the endocannabinoid system, and has an established role in promoting appetitive behavior; yet, it is still unknown if the OH system mediates food intake following cannabinoid administration.
View Article and Find Full Text PDFAm J Hypertens
September 2025
Laboratori ALIVEDA, Viale Karol Wojtyla 19, 56042 Crespina Lorenzana, Pisa, Italy.
The present State of the Art Review will take stock of targeting the endocannabinoid system (ECS) in the management of hypertension and vascular diseases. Major efforts have been made in the last thirty years to develop compounds modulating the ECS for diseases, both in the central and peripheral tissues. Agonists of the cannabinoid receptor CB1 elicited hypotension but were at strong risks of inducing tachycardia, heart and kidney damage.
View Article and Find Full Text PDFNeuropsychopharmacology
August 2025
School of Psychological Sciences, Department of Psychology, University of Haifa, Haifa, 3498838, Israel.
Cognitive decline is a hallmark of Alzheimer's disease (AD). Cannabidiol (CBD), a non-intoxicating phytocannabinoid with immunomodulatory properties, shows promise in alleviating AD symptoms. This study examined the effects of chronic CBD treatment in a male rat model of sporadic AD induced by intracerebroventricular streptozotocin (ICV-STZ) and explored its impact on neuroinflammatory genes and cannabinoid signaling.
View Article and Find Full Text PDFBiomedicines
August 2025
Department of Neurological Surgery, School of Medicine, University of California Davis, 4610 X Street, Sacramento, CA 95817, USA.
Cannabinoid use is rising among patients undergoing spinal fusion, yet its influence on bone healing is poorly defined. The endocannabinoid system (ECS)-through cannabinoid receptors 1 (CB1) and 2 (CB2)-modulates skeletal metabolism. We reviewed preclinical, mechanistic and clinical evidence to clarify how individual cannabinoids affect fracture repair and spinal arthrodesis.
View Article and Find Full Text PDFTransl Neurodegener
August 2025
Departament de Biomedicina, Facultat de Medicina I Ciències de La Salut, Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain.
Background: Dysregulation of the endocannabinoid system (eCBS) and the loss of CB1 receptors (CB1R) in the basal ganglia are well-established hallmarks of Huntington's disease (HD). As a result, significant research efforts have focused on targeting the eCBS to alleviate motor disturbances associated with the disease. Beyond its role in motor control, the eCBS is a complex signaling network critically involved in regulating learning and memory.
View Article and Find Full Text PDF